Kaichuan Zhu

ORCID: 0000-0002-1868-5082
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Neuroscience and Neuropharmacology Research
  • Cholinesterase and Neurodegenerative Diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Inflammation biomarkers and pathways
  • Computational Drug Discovery Methods
  • Anesthesia and Neurotoxicity Research
  • HIV Research and Treatment
  • Prion Diseases and Protein Misfolding
  • Amino Acid Enzymes and Metabolism
  • Advanced battery technologies research
  • Memory and Neural Mechanisms
  • Tryptophan and brain disorders

Shenzhen Institutes of Advanced Technology
2023-2024

Chinese Academy of Sciences
2023-2024

German Center for Neurodegenerative Diseases
2016-2023

Ludwig-Maximilians-Universität München
2016-2018

Munich Cluster for Systems Neurology
2016-2018

The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases risk for late onset Alzheimer's disease. Mouse models accurately reproducing phenotypes observed in Alzheimer' disease patients carrying coding are required to understand TREM2 related dysfunctions responsible enhanced A CRISPR/Cas9-assisted gene targeting strategy was used generate Trem2 knock-in mice. mRNA and protein levels as well splicing patterns were assessed these mice,...

10.1186/s13024-018-0280-6 article EN cc-by Molecular Neurodegeneration 2018-09-05

Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a promising drug target for the treatment of Alzheimer's disease. Prolonged BACE1 inhibition interferes with structural and functional synaptic plasticity in mice, most likely by altering metabolism substrates. Seizure 6 (SEZ6) predominantly cleaved BACE1, Sez6 knockout mice share some phenotypes inhibitor-treated mice. We investigated whether SEZ6 involved inhibition-induced alterations.The function NB-360, novel blood-brain...

10.1016/j.biopsych.2016.12.023 article EN cc-by-nc-nd Biological Psychiatry 2016-12-26

Triggering receptor expressed on myeloid cell 2 (TREM2), a cell-specific signaling molecule, controls essential functions of microglia and impacts the pathogenesis Alzheimer's disease other neurodegenerative disorders. TREM2 is also highly in tumor-associated macrophages different types cancer. Here, we studied whether influences glioma progression. We found gender-dependent effect growth wild-type (WT) animals injected with GL261-EGFP cells. Most importantly, promotes progression male but...

10.1002/glia.24456 article EN cc-by Glia 2023-08-28

Abstract Dynamic synapses facilitate activity‐dependent remodeling of neural circuits, thereby providing the structural substrate for adaptive behaviors. However, mechanisms governing dynamic in adult brain are still largely unknown. Here, we demonstrate that cortex amyloid precursor protein knockout ( APP ‐ KO ) mice, spine formation and elimination were both reduced while overall density remained unaltered. When housed under environmental enrichment, mice failed to respond with an increase...

10.15252/embj.201694085 article EN cc-by-nc-nd The EMBO Journal 2016-08-29

It has been hypothesised that inhalational anaesthetics such as isoflurane (Iso) may trigger the pathogenesis of Alzheimer's disease (AD), while gaseous anaesthetic xenon (Xe) exhibits many features a putative neuroprotective agent. Loss synapses is regarded one key cause dementia in AD. Multiple EGF-like domains 10 (MEGF10) phagocytic receptors which assists elimination by astrocytes. Here, we investigated how β-amyloid peptide 1-42 (Aβ1-42), Iso and Xe interact with MEGF10-dependent...

10.3390/ijms24020912 article EN International Journal of Molecular Sciences 2023-01-04

Abstract INTRODUCTION More robust non‐human primate models of Alzheimer's disease (AD) will provide new opportunities to better understand the pathogenesis and progression AD. METHODS We designed a CRISPR/Cas9 system achieve precise genomic deletion exon 9 in cynomolgus monkeys using two guide RNAs targeting 3′ 5′ intron sequences PSEN1 9. performed biochemical, transcriptome, proteome, biomarker analyses characterize cellular molecular dysregulations this model. RESULTS observed early...

10.1002/alz.14046 article EN cc-by-nc-nd Alzheimer s & Dementia 2024-07-07

Abstract TREM2, a myeloid cell-specific signaling molecule, controls essential functions of microglia and impacts on the pathogenesis Alzheimer’s disease other neurodegenerative disorders. TREM2 is also highly expressed in tumor-associated macrophages plays detrimental roles an experimental mouse sarcoma model. Here we studied whether influences glioma progression. We found sex- dependent effect TREM2: volume significantly attenuated TREM2- deficient male but not female mice injected with...

10.1101/2023.05.18.540621 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-05-19
Coming Soon ...